SAN FRANCISCO and WASHINGTON Nov. 14 2011 PRNewswire Nektar Therapeutics NASDAQ NKTR announced today that positive preclinical data for NKTR192 a novel muopioid agonist was presented at the 41st Annual Meeting of the Society for Neuroscience being held No...
↧